Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins

Abstract

The galactose-targeting ligand induced substantial increases in transfection over non-targeted formulations when DOPE was included, indicating the potential for targeted gene delivery using CD-based delivery systems.